Update on the role of acyl-CoA:cholesterol acyltransferase inhibitors in atherosclerosis

Author： Wu Justina   Fishelevich Rita   Rodriguez Annabelle   Doshi Rajiv  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.11, 2001-11, pp. : 1655-1662

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel aryloxyalkylthioimidazoles as inhibitors of acyl-CoA: cholesterol-O-acyltransferase

By Bani M.   Bormetti R.   Ceccarelli W.   Fiocchi R.   Gobetti M.   Lombroso M.   Magnetti S.   Olgiati V.   Palladino M.   Villa M.   Vanotti E.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 1, 1995-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Acyl coenzyme A:cholesterol acyltransferase inhibition: potential atherosclerosis therapy or springboard for other discoveries?

By Heinonen Therese M  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol

By Tani Shigemasa   Nagao Ken   Hirayama Atsushi  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

Predicting Acyl-Coenzyme A: Cholesterol O-Acyltransferase Inhibitory Activity: Computational Approach Using Topological Descriptors

By LATHER VINEY   MADAN A. K.  

Drug Design and Discovery, Vol. 18, Iss. 4, 2003-01 ,pp. : 117-122

Taylor & Francis Ltd

Access to resources Recommend Favorite

Role of Anti-Oxidants in Atherosclerosis: Epidemiological and Clinical Update

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2017-2032

Bentham Science Publishers

Access to resources Recommend Favorite